TY - JOUR
T1 - Direct photolysis of human metabolites of the antibiotic sulfamethoxazole
T2 - Evidence for abiotic back-transformation
AU - Bonvin, Florence
AU - Omlin, Julien
AU - Rutler, Rebecca
AU - Schweizer, W. Bernd
AU - Alaimo, Peter J.
AU - Strathmann, Timothy J.
AU - McNeill, Kristopher
AU - Kohn, Tamar
PY - 2013/7/2
Y1 - 2013/7/2
N2 - The presence of potentially persistent and bioactive human metabolites in surface waters gives rise to concern; yet little is known to date about the environmental fate of these compounds. This work investigates the direct photolysis of human metabolites of the antibiotic sulfamethoxazole (SMX). In particular, we determined photolysis kinetics and products, as well as their concentrations in lake water. SMX, N-acetyl sulfamethoxazole, sulfamethoxazole β-d-glucuronide, 4-nitroso sulfamethoxazole, and 4-nitro sulfamethoxazole were irradiated under various light sources and pH conditions. All investigated metabolites, except sulfamethoxazole β-d-glucuronide were found to be more photostable than SMX under environmentally relevant conditions. Between two and nine confirmed photoproducts were identified for SMX-metabolites through ultraperformance liquid chromatography/high-resolution mass spectrometry. Interestingly, photolytic back-transformation to SMX was observed for 4-nitroso-SMX, indicating that this metabolite may serve as an environmental source of SMX. Moreover, two human metabolites along with SMX were regularly detected in Lake Geneva. The knowledge that some metabolites retain biological activity, combined with their presence in the environment and their potential to retransform to the parent compound, underlines the importance of including human metabolites when assessing the effects of pharmaceuticals in the environment.
AB - The presence of potentially persistent and bioactive human metabolites in surface waters gives rise to concern; yet little is known to date about the environmental fate of these compounds. This work investigates the direct photolysis of human metabolites of the antibiotic sulfamethoxazole (SMX). In particular, we determined photolysis kinetics and products, as well as their concentrations in lake water. SMX, N-acetyl sulfamethoxazole, sulfamethoxazole β-d-glucuronide, 4-nitroso sulfamethoxazole, and 4-nitro sulfamethoxazole were irradiated under various light sources and pH conditions. All investigated metabolites, except sulfamethoxazole β-d-glucuronide were found to be more photostable than SMX under environmentally relevant conditions. Between two and nine confirmed photoproducts were identified for SMX-metabolites through ultraperformance liquid chromatography/high-resolution mass spectrometry. Interestingly, photolytic back-transformation to SMX was observed for 4-nitroso-SMX, indicating that this metabolite may serve as an environmental source of SMX. Moreover, two human metabolites along with SMX were regularly detected in Lake Geneva. The knowledge that some metabolites retain biological activity, combined with their presence in the environment and their potential to retransform to the parent compound, underlines the importance of including human metabolites when assessing the effects of pharmaceuticals in the environment.
UR - http://www.scopus.com/inward/record.url?scp=84880121640&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84880121640&partnerID=8YFLogxK
U2 - 10.1021/es303777k
DO - 10.1021/es303777k
M3 - Article
C2 - 23186099
AN - SCOPUS:84880121640
SN - 0013-936X
VL - 47
SP - 6746
EP - 6755
JO - Environmental Science and Technology
JF - Environmental Science and Technology
IS - 13
ER -